Literature DB >> 21747096

Sex differences of urinary and kidney globotriaosylceramide and lyso-globotriaosylceramide in Fabry mice.

Brandon Durant1, Sabrina Forni, Lawrence Sweetman, Nastry Brignol, Xing-Li Meng, Elfrida R Benjamin, Raphael Schiffmann, Jin-Song Shen.   

Abstract

The aim of our study was to measure globotriaosylceramide (Gb(3)) and lyso-Gb(3) levels by tandem mass spectrometry in the urine and kidney in Fabry (gla knockout) mice and wild-type controls. We found that urine Gb(3) of male and female Fabry mice was higher than wild-type mice of the same sex but also significantly higher in male mice compared with females of the same genotype. In kidney tissue, sex and genotype-dependent differences in Gb(3) levels paralleled those in the urine. Isoforms C16, C22:1, and C24OHA were particularly higher in males compared with females in both wild-type and Fabry mice. Similarly, kidney lyso-Gb(3) concentrations were significantly higher in 12-month-old male Fabry mice than in their homozygous female counterparts. However, lyso-Gb(3) was undetectable in wild-type mice of both sexes. α-Galactosidase A activity and mRNA levels in kidney were significantly lower in male wild-type mice compared with female mice. This study shows the sex differences in kidney and urine Gb(3) and kidney lyso-Gb(3) levels in both wild-type and Fabry mice, and it suggests that these male-female differences should be taken into consideration when using murine models for Fabry disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21747096      PMCID: PMC3151694          DOI: 10.1194/jlr.M017178

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  25 in total

1.  Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.

Authors:  C M Eng; N Guffon; W R Wilcox; D P Germain; P Lee; S Waldek; L Caplan; G E Linthorst; R J Desnick
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

2.  Purification and properties of the two major isozymes of alpha-galactosidase from human placenta.

Authors:  J W Kusiak; J M Quirk; R O Brady
Journal:  J Biol Chem       Date:  1978-01-10       Impact factor: 5.157

3.  Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transfer.

Authors:  Jinhee Park; Gary J Murray; Advait Limaye; Jane M Quirk; Monique P Gelderman; Roscoe O Brady; Pankaj Qasba
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-06       Impact factor: 11.205

4.  Genetic control of glucuronidase induction in mice.

Authors:  R T Swank; K Paigen; R E Ganschow
Journal:  J Mol Biol       Date:  1973-12-05       Impact factor: 5.469

5.  Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency.

Authors:  R O Brady; A E Gal; R M Bradley; E Martensson; A L Warshaw; L Laster
Journal:  N Engl J Med       Date:  1967-05-25       Impact factor: 91.245

6.  Lipid composition of lysosomal multilamellar bodies of male mouse urine.

Authors:  S K Gross; P F Daniel; J E Evans; R H McCluer
Journal:  J Lipid Res       Date:  1991-01       Impact factor: 5.922

7.  Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice.

Authors:  Y A Ioannou; K M Zeidner; R E Gordon; R J Desnick
Journal:  Am J Hum Genet       Date:  2000-12-13       Impact factor: 11.025

8.  Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells.

Authors:  T Takenaka; G J Murray; G Qin; J M Quirk; T Ohshima; P Qasba; K Clark; A B Kulkarni; R O Brady; J A Medin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

9.  Synthesis and secretion of kidney beta-galactosidase in mutant le/le mice.

Authors:  M H Meisler
Journal:  J Biol Chem       Date:  1978-05-10       Impact factor: 5.157

10.  Testosterone effects on the induction and urinary excretion of mouse kidney glycosphingolipids associated with lysosomes.

Authors:  R H McCluer; M A Williams; S K Gross; M H Meisler
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

View more
  8 in total

1.  Interfering parameters in the determination of urinary globotriaosylceramide (Gb3) in patients with chronic kidney disease.

Authors:  Martina Gaggl; Marlene Hofer; Stefanie Weidner; Julia Kleinert; Günter Fauler; Manfred Wallner; Peter Kotanko; Eduard Paschke; Gere Sunder-Plassmann
Journal:  J Nephrol       Date:  2015-04-10       Impact factor: 3.902

2.  Assessing the role of glycosphingolipids in the phenotype severity of Fabry disease mouse model.

Authors:  Siamak Jabbarzadeh-Tabrizi; Michel Boutin; Taniqua S Day; Mouna Taroua; Raphael Schiffmann; Christiane Auray-Blais; Jin-Song Shen
Journal:  J Lipid Res       Date:  2020-08-31       Impact factor: 5.922

3.  Genetic, dietary, and sex-specific regulation of hepatic ceramides and the relationship between hepatic ceramides and IR.

Authors:  Frode Norheim; Thomas Bjellaas; Simon T Hui; Karthickeyan Chella Krishnan; Jakleen Lee; Sonul Gupta; Calvin Pan; Yehudit Hasin-Brumshtein; Brian W Parks; Daniel Y Li; Hai H Bui; Marian Mosier; Yuping Wu; Adriana Huertas-Vazquez; Stanley L Hazen; Thomas E Gundersen; Margarete Mehrabian; W H Wilson Tang; Andrea L Hevener; Christian A Drevon; Aldons J Lusis
Journal:  J Lipid Res       Date:  2018-05-08       Impact factor: 6.676

4.  Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry mice.

Authors:  Jin-Song Shen; Andreas Busch; Taniqua S Day; Xing-Li Meng; Chun I Yu; Paulina Dabrowska-Schlepp; Benjamin Fode; Holger Niederkrüger; Sabrina Forni; Shuyuan Chen; Raphael Schiffmann; Thomas Frischmuth; Andreas Schaaf
Journal:  J Inherit Metab Dis       Date:  2015-08-27       Impact factor: 4.982

5.  Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion.

Authors:  Mustafa A Kamani; Philippe Provençal; Michel Boutin; Natalia Pacienza; Xin Fan; Anton Novak; Tonny C Huang; Beth Binnington; Bryan C Au; Christiane Auray-Blais; Clifford A Lingwood; Jeffrey A Medin
Journal:  Future Sci OA       Date:  2016-10-13

6.  Reduced α-galactosidase A activity in zebrafish (Danio rerio) mirrors distinct features of Fabry nephropathy phenotype.

Authors:  Hassan O A Elsaid; Jessica Furriol; Maria Blomqvist; Mette Diswall; Sabine Leh; Naouel Gharbi; Jan Haug Anonsen; Janka Babickova; Camilla Tøndel; Einar Svarstad; Hans-Peter Marti; Maximilian Krause
Journal:  Mol Genet Metab Rep       Date:  2022-02-17

7.  Migalastat HCl reduces globotriaosylsphingosine (lyso-Gb3) in Fabry transgenic mice and in the plasma of Fabry patients.

Authors:  Brandy Young-Gqamana; Nastry Brignol; Hui-Hwa Chang; Richie Khanna; Rebecca Soska; Maria Fuller; Sheela A Sitaraman; Dominique P Germain; Roberto Giugliani; Derralynn A Hughes; Atul Mehta; Kathy Nicholls; Pol Boudes; David J Lockhart; Kenneth J Valenzano; Elfrida R Benjamin
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

8.  Gender, Contraceptives and Individual Metabolic Predisposition Shape a Healthy Plasma Lipidome.

Authors:  Susanne Sales; Juergen Graessler; Sara Ciucci; Rania Al-Atrib; Terhi Vihervaara; Kai Schuhmann; Dimple Kauhanen; Marko Sysi-Aho; Stefan R Bornstein; Marc Bickle; Carlo V Cannistraci; Kim Ekroos; Andrej Shevchenko
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.